Overview

Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Primary Dysmenorrhea

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether combination oral contraceptive pill of norethindrone and ethinyl estradiol is effective in the treatment of primary dysmenorrhea.
Phase:
Phase 3
Details
Lead Sponsor:
Nobelpharma
Treatments:
Anti-Inflammatory Agents, Non-Steroidal
Contraceptive Agents
Contraceptives, Oral
Contraceptives, Oral, Combined
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Ethinyl Estradiol
Norethindrone
Norethindrone acetate
Polyestradiol phosphate